Cell surface display of the chlamydial glycolipid exoantigen (GLXA) demonstrated by antibody-dependent complement-mediated cytotoxicity

Current Microbiology

Volumn 49, Issue 1, 2004, Pages 13-21

  Webley, Wilmore C ^a   Vora, Gary J ^b   Stuart, Elizabeth S ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b NAVAL RESEARCH LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BACTERIAL ANTIGEN; GLYCOLIPID; GLYCOLIPID EXOANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; ARTICLE; CELL CULTURE; CELL FUNCTION; CELL SURFACE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; COMPLEMENT DEPENDENT CYTOTOXICITY; CULTURE MEDIUM; HELA CELL; HOST CELL; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL;

BACTERIA (MICROORGANISMS); CHLAMYDIA TRACHOMATIS; CHLAMYDIAE; CHLAMYDOPHILA; CHLAMYDOPHILA PNEUMONIAE; NEGIBACTERIA; RICKETTSIALES;

EID: 3142718930     PISSN: 03438651     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00284-003-4181-7     Document Type: Article

References (50)

1. An LL, Hudson AP, Prendergast RA, O'Brien TP, Stuart ES, Whittum-Hudson JA, MacDonald AB (1997) Biochemical and functional antigenic mimicry by a polyclonal anti-idiotypic antibody for chlamydial exoglycolipid antigen. Pathobiology 65:229-240
2. Balin BJ, Gerard HC, Arking EJ, Appelt DM, Branigan PJ, Abrams JT, Whittum-Hudson JA, Hudson AP (1998) Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Med Microbiol Immunol 187:23-42
3. Bodetti TJ, Timms P (2000) Detection of Chlamydia pneumoniae DNA and antigen in the circulating mononuclear cell fractions of humans and koalas. Infect Immun 6:2744-2747
4. Byrne GI, Kalayoglu MV (1999) Chlamydia pneumoniae and atherosclerosis: links to the disease process. Am Heart J 138: S488-S490
5. Campbell LA, Kuo CC, Grayston JT (1998) Chlamydia pneumoniae and cardiovascular disease. Emerg Infect Dis 4:571-579
6. Cotter TW, Ramsey KH, Miranpuri GS, Poulsen CE, Byrne GI (1997) Dissemination of Chlamydia trachomatis chronic genital tract infection in gamma interferon gene knockout mice. Infect Immun 65:2145-2152
7. Everett KD, Bush RM, Andersen AA (1999) Emended description of the order Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkaniaceae fam. nov., each containing one monotypic genus, revised taxonomy of the family Chlamydiaceae, including a new genus and five new species, and standards for the identification of organisms. Int J Syst Bacteriol 49:415-440
8. Fan P, Dong F, Huang Y, Zhong G (2002) Chlamydia pneumoniae secretion of a protease-like activity factor for degrading host cell transcription factors is required for major histocompatibility complex antigen expression. Infect Immun 70:345-349
9. Fan T, Lu H, Hu H, Shi L, McClarty GA, Nance DM, Greenberg AH, Zhong G (1998) Inhibition of apoptosis in Chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation. J Exp Med 187:487-496
10. Fields BA, Goldbaum FA, Ysern X, Poljak RJ, Martiuza RA (1995) Molecular basis of antigen mimicry by an anti-idiotype. Proc Natl Acad Sci USA 374:739-742
11. Gaydos CA, Summersgill JT, Sahney NN, Ramirez JA, Quinn TC (1996) Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immun 64:1614-1620
12. Gerard HC, Schumacher HR, El-Gabalawy H, Goldbach-Mansky R, Hudson AP (2000) Chlamydia pneumoniae present in the human synovium are viable and metabolically active. Microb Pathog 29:17-24
13. Haranaga S, Yamaguchi H, Lepare GF, Friedman H, Yamamoto Y (2001) Detection of Chlamydia pneumoniae antigen in PBMCs of healthy blood donors. Transfusion 41:1114-1119
14. Howard JG (1987) T cell-independent responses to polysaccharides: their nature and delayed ontogeny. In: Bell R, Torrigiani G (eds) Towards better carbohydrate vaccines. London: John Wiley and Sons Ltd., pp. 221-231
15. Jerne NK (1974) Towards a network theory of the immune system. Ann Immunol 125:373-389
16. Kalayoglu MV, Indrawati, Morrison RP, Morrison SG, Yuan Y, Byrne GI (2000) Chlamydial virulence determinants in atherogenesis: the role of chlamydial lipopolysaccharide and heat shock protein 60 in macrophage- lipoprotein interactions. J Infect Dis 18:S483-S489
17. Kaul R, Uphoff J, Wiedeman J, Yadlapalli S, Wenman WM (2000) Detection of Chlamydia pneumoniae DNA in CD3+ lymphocytes from healthy blood donors and patients with coronary artery disease. Circulation 102:2341-2346
18. Kuo CC, Shor A, Campbell LA, Fukushi H, Patton DL, Grayston JT (1993) Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 167:841-849
19. Kuo C, Takahashi N, Swanson AF, Ozeki Y, Hakomori S (1996) An N-linked high-mannose type oligosaccharide, expressed at the major outer membrane protein of Chlamydia trachomatis, mediates attachment and infectivity of the microorganism to HeLa cells. J Clin Invest 98:2813-2818
20. Layh-Schmitt G, Bendl GC, Hildt U, Dong-Si T, Juttler E, Schnitzler P, Grond-Ginsbach C, Grau AJ (2000) Evidence for infection with Chlamydia pneumoniae in a subgroup of patients with multiple sclerosis. Ann Neurol 47:652-655
21. Lesinski GB, Westerink MA (2001) Novel vaccine strategies to T-independent antigens. J Microbiol Methods 47:135-149
22. Lin JS, Yan LL, Ho Y, Rice PA (1992) Early complement components enhance neutralization of Chlamydia trachomatis infectivity by human sera. Infect Immun 60:2547-2550
23. Liu MA (1998) Vaccine developments. Nat Med 4:515-519
24. MacDonald AB, An LL, Stuart ES, Whittum-Hudson JA (1998) Vaccine comprising anti-idiotypic antibody to chlamydial GLXA and process. US Patent #5,840,297
25. Mayr M, Metzler B, Kiechl S, Willeit J, Schett G, Xu Q, Wick G (1999) Endothelial cytotoxicity mediated by serum antibodies to heat shock proteins of Escherichia coli and Chlamydia pneumoniae: immune reactions to heat shock proteins as a possible link between infection and atherosclerosis. Circulation 99:1560-1566
26. Megran DW, Stiver HG, Peeling R, Maclean IW, Brunham RC (1988) Complement enhancement of neutralizing antibody to the structural proteins of Chlamydia trachomatis. J Infect Dis 158: 661-663
27. Morrison SG, Su H, Caldwell HD, Morrison RP (2000) Immunity to murine Chlamydia trachomatis genital tract reinfection involves B cells and CD4 (+) T cells but not CD8(+) T cells. Infect Immun 68:6979-6987
28. Niculescu F, Rus H (1999) Complement activation and atherosclerosis. Mol Immunol 36:949-955
29. Perry LL, Hughes S (1999) Chlamydial colonization of multiple mucosae following infection by any mucosal route. Infect Immun 67:3686-3689
30. Puolakkainen M, Parker J, Kuo CC, Grayston JT, Campbell LA (1995) Further characterization of Chlamydia pneumoniae specific monoclonal antibodies. Microbiol Immunol 39:551-554
31. Rajalingham K, Al-Younes H, Muller A, Meyer TF, Szczepk AJ, Rudel T (2001) Epithelial cells infected with Chlamydophila pneumoniae (Chlamydia pneumoniae) are resistant to apoptosis. Infect Immun 69:7880-7888
32. Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Makela PH, Huttunen JK, Valtonen V (1988) Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 2:983-986
33. Schachter J (1999) Infection and disease epidemiology. In: Stephens R (ed) Chlamydia: intracellular biology, pathogenesis, and immunity. Washington, DC: ASM Press, pp 139-169
34. Sessa R, Pietro M, Schiavoni G, Santino I, Cipriani P, Romano S, Penco M, del Piano M (2001) Prevalence of Chlamydia pneumoniae in peripheral blood mononuclear cells in Italian patients with acute ischemic heart disease. Atherosclerosis 159:521-525
35. Sriram S, Stratton CW, Yao S, Tharp A, Ding L, Bannan JD, Mitchell WM (1999) Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis. Ann Neurol 46:6-14
36. Stuart ES, MacDonald AB (1986) Genus glycolipid exoantigen from Chlamydia trachomatis: component preparation, isolation and analysis. In: Oriel D et al. (eds) Chlamydial infections. Cambridge: Cambridge University Press, pp 122-125
37. Stuart ES, MacDonald AB (1989) Some characteristics of a secreted chlamydial antigen recognized by IgG from C. trachomatis patient sera. Immunology 68:469-473
38. Stuart ES, Tirrell SM, MacDonald AB (1987) Characterization of an antigen secreted by Chlamydia-infected cell culture. Immunology 61:527-533
39. Stuart ES, Wyrick PB, Choong J, Stoler SB, MacDonald AB (1991) Examination of chlamydial glycolipid with monoclonal antibodies: cellular distribution and epitope binding. Immunology 74:740-747
40. Stuart ES, Troidle KM, MacDonald AB (1994) Chlamydial glycolipid antigen: extracellular accumulation, biological activity, and antibody recognition. Curr Microbiol 28:85-90
41. Su H, Raymond L, Rockey DD, Fischer E, Hackstadt T, Caldwell HD (1996) A recombinant Chlamydia trachomatis major outer membrane protein binds to heparan sulfate receptors on epithelial cells. Proc Natl Acad Sci USA 93:11143-11148
42. Swanson AF, Ezekowitz RA, Lee A, Kuo CC (1998) Human mannose-binding protein inhibits infection of HeLa cells by Chlamydia trachomatis. Infect Immun 66:1607-1612
43. Troidle KM (1992) Characterization of a genus-specific chlamydial antigen. Ph.D. thesis. Department of Microbiology, University of Massachusetts, Amherst, 129 pp.
44. Vlaicu R, Niculescu F, Rus HG, Cristea A (1985) Immunohistochemical localization of the terminal C5b-9 complement complex in human aortic fibrous plaque. Atherosclerosis 57:163-177
45. Vora G, Stuart ES (2003) A role for the glycolipid exoantigen (GLXA) in chlamydial infectivity. Curr Microbiol 46:217-223
46. Westerink MA, Apicella MA (1993) Anti-idiotypic antibodies as vaccines against carbohydrate antigens. Springer Semin Immunopathol 15:227-234
47. Whittum-Hudson J, Rudy D, Gerard HC, Vora G, Davis E, Haller PK, Prattis SM, Hudson AP, Saltzman WM, Stuart ES (2001) The anti-idiotypic antibody to chlamydial glycolipid exoantigen (GLXA) protects mice against genital infection with a human biovar of Chlamydia trachomatis. Vaccine 19:4061-4071
48. Wyrick PB (2000) Intracellular survival by Chlamydia. Cell Microbiol 2:275-282
49. Wyrick PB, Choong J, Knight S, Goyeau D, Stuart ES, MacDonald AB (1994) Chlamydia trachomatis antigens on the surface of infected human endometrial epithelial cells. Immunol Infect Dis 4:131-141
50. Zhang JP, Stephens RS (1992) Mechanism of C. trachomatis attachment to eukaryotic host cells. Cell 69:861-869